Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Strength Cond Res ; 38(5): 815-824, 2024 May 01.
Article in English | MEDLINE | ID: mdl-38662880

ABSTRACT

ABSTRACT: Stahl, CA, Regni, G, Tanguay, J, McElfresh, M, Trihy, E, Diggin, D, and King, DL. A biomechanical comparison of the back squat and hexagonal barbell deadlift. J Strength Cond Res 38(5): 815-824, 2024-Coaches often use different exercises to encourage similar strength adaptations and limit monotony. Anecdotally, the hexagonal barbell deadlift (HBD) exhibits similarities to the back squat (BS). To date, research has not examined the empirical differences between these exercises. This study examined kinematic and kinetic differences between the BS and the HBD across different loads. Sixteen resistance-trained individuals (6 men and 10 women) volunteered to participate. Subjects performed 1-repetition maximum (1RM) testing under BS and HBD conditions. Kinematic and kinetic data were collected during performance of both exercises at submaximal (warm-up sets) and maximal (1RM) loads using a 3D motion capture and force-plate system. Results showed that subjects lifted greater 1RM loads in the HBD relative to the BS (p < 0.05; d = -1.75). Kinematic data indicated that subjects exhibited greater maximum forward lean of the trunk and decreased maximum knee flexion while performing the HBD compared with the BS. The BS resulted in higher maximum extension moments at the hip joint than the HBD. Maximum extension moments at the knee joint showed no difference between the exercises. Data suggest that bar design and position facilitate balanced moment arm length at hip and knee joints during performance of the HBD. By contrast, bar position during performance of the BS increases moment arm length at the hip joint, making it a hip-dominant exercise. The present data have implications for the programming of both exercises. Future research should examine differences in muscle-activation strategies between the 2 exercises.


Subject(s)
Resistance Training , Weight Lifting , Humans , Biomechanical Phenomena , Male , Female , Resistance Training/methods , Weight Lifting/physiology , Young Adult , Adult , Muscle Strength/physiology , Muscle, Skeletal/physiology , Hip Joint/physiology
2.
Curr HIV Res ; 6(4): 296-305, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18691028

ABSTRACT

A good understanding about the structure and function of the envelope glycoprotein (Env) from primary human immunodeficiency virus-1 (HIV-1) isolates is important in facilitating the development of effective neutralizing antibody responses as a component of an effective HIV-1 vaccine. In the current study, the antigenicity of a panel of diverse HIV-1 primary Env from different clades of HIV-1 Group M was analyzed using rabbit sera produced by either 3- or 9-valent gp120 DNA vaccine formulations. Both the 3- and 9-valent gp120 DNA vaccine formulations elicited HIV-1 gp120-specific antibodies in immunized rabbits. However, we observed two levels of primary envelope antigenicity to the same set of rabbit immune sera and that the level of glycosylation, particularly in the V1 loop, may contribute to such diversity. Bioinformatics analysis on the distribution and average number of the N-linked glycosylation sites in all variable regions (V1-V5) was conducted. A linear plot demonstrated that the average number of potential N-glycosylation sites in the V1 and V4 loops correlates to the size of the loop. These data provide further evidence on the complexity of primary HIV-1 Env antigens and offers new insight into the mechanisms that HIV-1 uses to escape protective immune responses.


Subject(s)
AIDS Vaccines/immunology , HIV Antibodies/blood , HIV Antigens/immunology , HIV Envelope Protein gp120/chemistry , HIV-1/immunology , Peptide Fragments/chemistry , env Gene Products, Human Immunodeficiency Virus/immunology , AIDS Vaccines/administration & dosage , Amino Acid Sequence , Animals , Antigenic Variation , Female , Glycosylation , HIV Antigens/chemistry , HIV Antigens/genetics , HIV Antigens/metabolism , HIV Envelope Protein gp120/genetics , HIV Envelope Protein gp120/metabolism , HIV Infections/immunology , HIV Infections/prevention & control , HIV Infections/virology , HIV-1/classification , HIV-1/isolation & purification , Humans , Male , Molecular Sequence Data , Peptide Fragments/genetics , Peptide Fragments/metabolism , Rabbits , Structure-Activity Relationship , Vaccines, DNA/administration & dosage , Vaccines, DNA/immunology , env Gene Products, Human Immunodeficiency Virus/chemistry , env Gene Products, Human Immunodeficiency Virus/genetics , env Gene Products, Human Immunodeficiency Virus/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...